Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07273773 · ClinicalTrials.gov registry record · NA
Evaluation of the Rigicon Infla10® Inflatable Penile Prosthesis (IPP) for Erectile Dysfunction
A NA study of Erectile Dysfunction (ED), sponsored by Rigicon.
- Recruiting
- Registry status
- NA
- Development phase
- 182
- Enrollment target
- 7
- Study locations
NCT07273773 is a NA study of Erectile Dysfunction (ED) that is actively recruiting participants, run by Rigicon. The registered enrollment target is 182 participants. The trial reports 7 study locations across 6 states.
The verdict
NCT07273773, a NA study of Erectile Dysfunction (ED), is actively recruiting participants, sponsored by Rigicon.
- RECRUITING
- Registry status
- NA
- Development phase
- 182 participants
- Enrollment target
- 7
- Study locations
Study Summary
This study evaluates the long-term safety and effectiveness of the Rigicon Infla10® Inflatable Penile Prosthesis in patients with erectile dysfunction. The study follows patients implanted with the Rigicon Infla10® Pulse™ Dynamic Inflatable Penile Prosthesis for up to 3 years after implantation.
Conditions Studied
Interventions
- DEVICE Rigicon Infla10® Inflatable Penile Prosthesis (IPP)
Study Locations (7)
Texas
- Urology Partners of North Texas - Arlington
- Vitality Urology Institute - Houston
Florida
- Perito Urology - Coral Gables
Georgia
- Atlanta Cosmetic Urology - Atlanta
Illinois
- UroPartners - Chicago
Massachusetts
- Kramer Urology - Hyannis
New York
- Washington Heights Urology - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2026-01-26 |
| Est. Completion | 2029-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07273773
The ClinicalTrials.gov registry entry for NCT07273773 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rigicon, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Erectile Dysfunction (ED) appearing as the primary indexed condition, and to 1 intervention - of which Rigicon Infla10® Inflatable Penile Prosthesis (IPP) is the first listed.
NCT07273773 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Texas, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT07273773 about?
NCT07273773 is a clinical study titled "Evaluation of the Rigicon Infla10® Inflatable Penile Prosthesis (IPP) for Erectile Dysfunction". This study evaluates the long-term safety and effectiveness of the Rigicon Infla10® Inflatable Penile Prosthesis in patients with erectile dysfunction. The study follows patients implanted with the Rigicon Infla10® Pulse™ Dynamic Inflatable Penile Prosthesis for up to 3 years after implantation.
What is the current status of trial NCT07273773?
This trial is currently recruiting. It is a NA study. The enrollment target is 182 participants. The study started on 2026-01-26. Estimated completion is 2029-07.
What conditions does trial NCT07273773 study?
This clinical trial studies the following conditions: Erectile Dysfunction (ED).
What interventions are being tested in trial NCT07273773?
The interventions under investigation include: Rigicon Infla10® Inflatable Penile Prosthesis (IPP) (DEVICE).
Who is sponsoring clinical trial NCT07273773?
This trial is sponsored by Rigicon, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07273773 being conducted?
This trial has 7 study locations across Florida, Georgia, Illinois, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.